ReShape Lifesciences Nachrichten und Aktivitäten

Fusion, Akquisition und Finanzierung mit ReShape Lifesciences.

• Vyome Therapeutics and ReShape Lifesciences have announced they will merge  (veröffentlicht am 14, Januar 2025)..

Siehe das Organigramm mit seine 9 wichtigsten Führungskräfte

Die meist gesuchten Biographien bei ReShape Lifesciences

• Barton Bandy, Director and Chief Executive Officer
• Dan Gladney, Chairman of the Board
• Lori McDougal, Director

Eine Benachrichtigung erstellen
um Veränderungen bei Führungskräften von ReShape Lifesciences nachzuverfolgen.

ReShape Lifesciences hat 1.919 Konkurrenten , einschließlich Sanofi (Frankreich), Moderna (USA) und Eli Lilly (USA).

Popular M&A news in Pharmazie

• Eli Lilly has announced the acquisition of AtaiBeckley  (veröffentlicht am 17, Juli 2026).
• Agenus hat gerade eine Spendenaktion von 340 Millionen Dollar angekündigt. (veröffentlicht am 17, Juli 2026).
• GSK hat Nuvalent erworben (veröffentlicht am 17, Juli 2026).

Andere vorgeschlagene Kontakte der Pharmazie branche

• David Ricks - President, Chief Executive Officer and Chairman of the Board bei Eli Lilly
• Joaquin Duato - Chief Executive Officer and Chairman of the Board bei Johnson & Johnson
• Richard Saynor - Chief Executive Officer bei Sandoz

Mehr über die Pharmazie branche erfahren

Neueste Pressemitteilungen nach ReShape Lifesciences

• News - Medtimo
• News - Medtimo
• News - Medtimo
• Press Releases | ReShape Lifesciences
• ReShape Lifesciences Announces Appointment of Paul F. Hickey as President and Chief Executive Officer | ReShape Lifesciences
• ReShape Lifesciences Enters into Warrant Exercise Transaction for $2.5 Million in Gross Proceeds | ReShape Lifesciences
• ReShape Lifesciences and OpenLoop Sign Agreement to Provide Nationwide Virtual Health Services for Weight Loss and Wellness Through reshapecare™ | ReShape Lifesciences
• ReShape Lifesciences™ Reports First Quarter 2022 Financial Results and Provides Corporate Update | ReShape Lifesciences
• ReShape Lifesciences™ Announces Vernon Vincent to be Recognized as the Distinguished Industry Partner at the ASMBS 2022 LEAD Gala and Awards | ReShape Lifesciences
• ReShape Lifesciences™ to Announce Financial Results for the First Quarter Ended March 31, 2022 and Provide Corporate Update | ReShape Lifesciences
• View more press releases Close

Social media about ReShape Lifesciences

• ReShape Lifesciences auf Wikipedia, Google News & Yahoo Finance
• ReShape Lifesciences auf LinkedIn, X (Twitter) & YouTube